Sk Life Science, Inc.

This study tests cenobamate, an approved seizure drug, when used alone in adults with newly diagnosed or recurrent partial-onset epilepsy. About 49 participants will take either 100 mg or 200 mg daily to see if they become seizure-free for 26 weeks. The goal is to gather more dat…

This study looks at the long-term safety of the drug cenobamate when added to other seizure medications. It is for people who have primary generalized tonic-clonic seizures and have already completed a previous study. Researchers will monitor side effects and overall health for 5…